INS and Hypoglycemia: The effect of metformin on early and long-term clinical outcomes of ACS is not well known, insulin therapy is associated with potentially dangerous hypoglycemia in ACS, and the use of other antihyperglycemic drugs to prevent cardiovascular events in the above category of patients remains understudied.